- Home
- CTMX vs TBNK Comparison
CTMX vs TBNK Comparison
Compare CTMX & TBNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- TBNK
- Stock Information
- Founded
- CTMX 2008
- TBNK 1921
- Country
- CTMX United States
- TBNK United States
- Employees
- CTMX N/A
- TBNK N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- TBNK Savings Institutions
- Sector
- CTMX Health Care
- TBNK Finance
- Exchange
- CTMX Nasdaq
- TBNK Nasdaq
- Market Cap
- CTMX 62.3M
- TBNK 65.7M
- IPO Year
- CTMX 2015
- TBNK N/A
- Fundamental
- Price
- CTMX $0.58
- TBNK $8.33
- Analyst Decision
- CTMX Buy
- TBNK Hold
- Analyst Count
- CTMX 6
- TBNK 2
- Target Price
- CTMX $5.77
- TBNK $9.89
- AVG Volume (30 Days)
- CTMX 3.8M
- TBNK 12.4K
- Earning Date
- CTMX 03-06-2025
- TBNK 05-02-2025
- Dividend Yield
- CTMX N/A
- TBNK 0.48%
- EPS Growth
- CTMX N/A
- TBNK N/A
- EPS
- CTMX 0.38
- TBNK N/A
- Revenue
- CTMX $138,103,000.00
- TBNK $36,403,000.00
- Revenue This Year
- CTMX N/A
- TBNK $5.07
- Revenue Next Year
- CTMX N/A
- TBNK $14.93
- P/E Ratio
- CTMX $1.57
- TBNK N/A
- Revenue Growth
- CTMX 36.45
- TBNK N/A
- 52 Week Low
- CTMX $0.56
- TBNK $6.92
- 52 Week High
- CTMX $5.85
- TBNK $11.44
- Technical
- Relative Strength Index (RSI)
- CTMX 37.64
- TBNK 46.75
- Support Level
- CTMX $0.57
- TBNK $8.30
- Resistance Level
- CTMX $0.65
- TBNK $8.43
- Average True Range (ATR)
- CTMX 0.05
- TBNK 0.18
- MACD
- CTMX 0.00
- TBNK 0.03
- Stochastic Oscillator
- CTMX 15.04
- TBNK 44.64
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About TBNK Territorial Bancorp Inc.
Territorial Bancorp Inc operates as a bank holding company. It offers a wide variety of FDIC-insured deposit products and loan products for the consumer and small businesses. Its business consists of accepting deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, in one-to-four-family residential mortgage loans and investment securities. The company offers a variety of deposit accounts, including passbook and statement savings accounts, certificates of deposit, money market accounts, commercial and regular checking accounts and Super NOW accounts Its loan segment portfolio consists of Residential Mortgage; Construction, Commercial, and Other Mortgage Loans; Home Equity loans & line of credit; and Consumer & others.